Delivery Order SPE2DB20D2001-SPE2DB25FPNUA
- Not listed
- The Defense Logistics Agency awarded a $39,518.60 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Somatuline Depot 120 mg/0.5 ml injectable medication, with a completion date of September 15, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Somatuline Depot 90 mg/0.3 ml injectable medication. This firm fixed-price delivery order, valued at $11,233.02, represents a non-competitive child award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion blanket agreement running through December 2026. The product will be performed at...
- The Defense Logistics Agency awarded a $19,759.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Somatuline Depot 120 mg/0.5 ml injectable medication. This competitive award, issued on September 24, 2025, with an ultimate completion date of October 16, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The delivery location is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency Medical Supply Chain awarded a $15,807.44 delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Somatuline Depot 120 mg/0.5 mL injectable medication. The contract utilizes firm fixed-price pricing with a completion date of October 15, 2025, and carries no set-aside designation, indicating competitive award to this qualified vendor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery...
- The Defense Logistics Agency awarded a delivery order valued at $5,616.51 to AmerisourceBergen Drug Corp for the supply of Somatuline Depot 90 mg/0.3 ml injectable medication. This is a firm fixed price, competitively awarded contract with no set-aside designation, featuring an ultimate completion date of May 22, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,951.86 to AmerisourceBergen Drug Corp for the supply of Somatuline Depot 120 mg/0.5 ml injections. The award, issued on September 9, 2025, is a firm fixed-price delivery order with an ultimate completion date of September 30, 2025. The contract is non-set-aside and competitively awarded, with performance of work taking place at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency Troop Support Medical awarded a $9,526 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120mg/0.5ml doses of Somatuline Depot, a medication used to treat symptoms of neuroendocrine tumors. The order is for a half milliliter quantity of the drug to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania to an unspecified location by September 29, 2023, fulfilling requirements under the agency's...
- The Defense Logistics Agency awarded a $25,062 delivery order to Amerisourcebergen Drug Corporation for the supply of Somatuline Depot 120 mg/0.5 ml injections. The firm fixed price order is to provide 0.5 ml injections of Somatuline Depot, used to treat symptoms associated with neuroendocrine tumors. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania, spanning from September 11, 2023 through October 2, 2023. No subcontractors or set aside designations were...
- The Defense Logistics Agency awarded a $5,386.63 delivery order contract to Amerisourcebergen Drug Corporation for the supply of Somatuline Depot 90 mg/0.3 ml prefilled syringes. Under the terms of the firm fixed price contract, Amerisourcebergen will deliver 0.3 ml doses of the drug to a location in Conshohocken, Pennsylvania by October 4, 2023. Somatuline Depot is a long-acting somatostatin analog used to treat acromegaly and gastroenteropancreatic neuroendocrine tumors. The award was made...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Somatuline Depot 120 mg/0.5 ml injectable medication, with a contract ceiling value of $23,711.16. This is a firm fixed-price delivery order with no set-aside designation, demonstrating AmerisourceBergen's qualification to compete in open federal procurement. The order is scheduled for completion by October 7, 2025, and will be performed at the...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB25FPNUADelivery Order
The Defense Logistics Agency awarded a $5,616.51 delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Somatuline Depot 90 mg/0.3 ml injectable medication. This is a firm fixed price delivery order with no set-aside designation, utilizing open competition. The order is scheduled for ultimate completion by October 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Somatuline Depot is a somatostatin analog used primarily in the treatment of acromegaly and neuroendocrine tumors, representing a specialized pharmaceutical product within the Defense Health Agency's medical supply requirements. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. AmerisourceBergen serves as a major pharmaceutical distributor for federal medical procurement and maintains significant capacity to supply brand-name and generic medications, specialty drugs, vaccines, and medical devices to military and veteran healthcare systems. The company's extensive federal contracting history demonstrates consistent capability to meet competitive procurement requirements across the Defense Health System's diverse pharmaceutical needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 9/22/25 |